Novo Nordisk's pricing techniques in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, pointing out the stark distinction concerning U.S. prices and those in Europe and copyright.This led Novo Nordisk to carry out additional analysis into greater dosages of semaglutide especially